New Alzheimer’s Mechanism Links APP and Hv1 Channels in Brain Inflammation
Irvine, Calif. – October 23, 2025 Researchers at the University of California, Irvine have uncovered a previously unrecognised molecular...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Irvine, Calif. – October 23, 2025 Researchers at the University of California, Irvine have uncovered a previously unrecognised molecular...
